UCB Japan Co., Ltd. Announces Sales Channel Change Of Zyrtec Tablet In Japan
10/19/2005 5:13:08 PM
Tokyo (JCNN) - On April 18, UCB Japan announced its decisions on the domestic distribution of Zyrtec.
Launched in Japan in September 1998, Zyrtec is an antiallergic agent used in over 100 countries worldwide.
First, UCB Japan has agreed with its sales partner Sumitomo Pharmaceuticals to terminate the distribution agreement for Zyrtec, effective June 30.
comments powered by